|
TGA, Australia Recalls Sartans due to Azide Impurity
|
|
0
|
360
|
October 15, 2021
|
|
Summary of current Nitrosamine Regulatory scenario
|
|
0
|
292
|
October 15, 2021
|
|
Advices are needed for LTL approach
|
|
4
|
473
|
October 15, 2021
|
|
Impact of Stability and Transportation on APIs
|
|
3
|
393
|
October 13, 2021
|
|
Do we need to study Nitrosamine impurity for Topical creams/ointments?
|
|
15
|
1409
|
October 13, 2021
|
|
IQ Consortium Virtual CMC summit (Oct 13th)
|
|
0
|
248
|
October 5, 2021
|
|
FDA alerts to a voluntary recall of varenicline - What do we know?
|
|
17
|
1322
|
September 30, 2021
|
|
PhARMA - Global Workshop on Nitrosamine *FREE*
|
|
7
|
616
|
September 28, 2021
|
|
Impurities Training Course
|
|
0
|
278
|
September 24, 2021
|
|
Results from survey on Nitrosamines in Excipients -Any thoughts?
|
|
10
|
769
|
September 23, 2021
|
|
Excipient & Nitrosamines -Q&A session
|
|
0
|
333
|
September 16, 2021
|
|
Industry Survey USP APIs/Excipients *Closing Aug 31st*
|
|
2
|
525
|
September 16, 2021
|
|
So… the Nitrosamines crisis unfolding into judicial consequences
|
|
0
|
303
|
September 13, 2021
|
|
How does your Nitrosamine Team operates?
|
|
3
|
312
|
September 12, 2021
|
|
Adding trapping agents capable of scavenging adventitious nitrosating agents?
|
|
9
|
837
|
September 9, 2021
|
|
Test methods for Nitrosamines & Azido compounds in Sartans published by Taiwan FDA
|
|
0
|
290
|
September 9, 2021
|
|
Test method for AZBT & AZBC in Sartans published by Swiss Medic
|
|
0
|
207
|
September 9, 2021
|
|
Risk based approach to evaluate Nitrosamines by Merck
|
|
0
|
309
|
September 9, 2021
|
|
CDER conducts Lab & Clinical studies to evaluate NDMA production from Ingested Ranitidine products
|
|
0
|
242
|
September 8, 2021
|
|
Screening vs **Risk Assessment**?
|
|
11
|
621
|
September 7, 2021
|
|
TEVA-API Nitrosamine Webinar
|
|
0
|
313
|
September 6, 2021
|
|
USP-IPA Excipient composition and impurities
|
|
0
|
224
|
September 6, 2021
|
|
MHRA recalls Metformin Oral solution
|
|
14
|
421
|
September 3, 2021
|
|
FDA Workshop: 2021 Generic Drug Science & Research Priority Initiatives
|
|
1
|
219
|
September 1, 2021
|
|
Inhibition of N-nitrosamine in Drug Product, model says YES!
|
|
4
|
717
|
August 31, 2021
|
|
Nitrosamine in Biologic Products
|
|
6
|
897
|
August 10, 2023
|
|
Brazilian focus on Nitrosamines
|
|
0
|
250
|
August 26, 2021
|
|
Q&A Nitrosamine SAR working group (23 companies and universities)
|
|
12
|
1521
|
August 25, 2021
|
|
PharmaLytica Online 2021
|
|
0
|
207
|
August 25, 2021
|
|
Why LTL approach is not been considered?
|
|
18
|
2427
|
August 25, 2021
|